...
首页> 外文期刊>Clinical neurophysiology >Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome.
【24h】

Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome.

机译:MECP2突变的Rett综合征的耐药性癫痫和癫痫表型-EEG关联。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To determine in MECP2-mutated Rett syndrome (RTT [MIM 312750]): (1) the prevalence of drug-resistant epilepsy (DRE); (2) whether the presence of DRE is related to the abnormal EEG patterns or to the particular MECP2 mutant genotype. METHODS: Retrospective survey of a large population of patients (n=154) evaluated between 1978 to 2007 (May) at the Child Psychiatry and Neurology Unit of Siena (Italy) with both clinical and genetic (i.e. MECP2 mutated) diagnoses of RTT. Some subjects were followed for up to 20 years. Among those, cases with epilepsy were first selected for study; within that group, cases with DRE were identified and studied. The association between clinical severity of their epilepsy and quantitative or qualitative scores of EEG severity was tested using rank coefficients (Spearman's rho values). The relationship between DRE and RTT genotype category (i.e. gene deletion, gene duplication, early truncating mutation, late truncating mutation, and missense mutation) or a specific MECP2 genotype was tested using the chi-square test. A p-value <0.05 (two sided) was considered to indicate statistical significance. RESULTS: Prevalence of DRE was 16% (i.e. 16 DRE out of 100 MECP2-mutated RTT epileptic patients). No significant relationship was found between clinical severity of DRE and quantitative (p=0.9190) or qualitative EEG scores (p=0.1511). In addition, no significant relationship was found between the DRE and the RTT genotype category (chi-square=1.147, DF=4, p=0.8867), or a specific MECP2 genotype (chi-square=30.958, DF=39, p=0.8173). CONCLUSIONS: Although RTT MECP2-mutated patients suffer from a serious and progressive encephalopathy, it is epileptogenic compared to the general epileptic population (DRE: 20-40%). The presence of DRE is not related to abnormal EEG findings or a particular MECP2 mutant genotype. SIGNIFICANCE: These observations could be of help in the practical management and family counseling.
机译:目的:确定MECP2突变的Rett综合征(RTT [MIM 312750]):(1)耐药性癫痫(DRE)的患病率; (2)DRE的存在与异常的EEG模式或特定的MECP2突变基因型有关。方法:回顾性调查了1978年至2007年(5月)在锡耶纳(意大利)的儿童精神病学和神经病学部门接受临床和遗传(即MECP2突变)诊断的RTT的大量患者(n = 154)。一些受试者被随访长达20年。其中,首先选择癫痫病例进行研究。在该组中,确定并研究了DRE病例。使用等级系数(Spearman的rho值)测试癫痫的临床严重程度与EEG严重程度的定量或定性评分之间的关​​联。使用卡方检验测试了DRE与RTT基因型类别(即基因缺失,基因重复,早期截短突变,晚期截短突变和错义突变)或特定MECP2基因型之间的关系。 p值<0.05(双面)被认为表明统计学意义。结果:DRE的患病率为16%(即100名MECP2突变的RTT癫痫患者中有16名DRE)。在DRE的临床严重程度与定量(p = 0.9190)或定性EEG评分(p = 0.1511)之间没有发现显着关系。此外,在DRE和RTT基因型类别(卡方= 1.147,DF = 4,p = 0.8867)或特定的MECP2基因型(卡方= 30.958,DF = 39,p = 0.8173)。结论:尽管RTT MECP2突变的患者患有严重的进行性脑病,但与普通癫痫病人群相比,它具有致痫性(DRE:20-40%)。 DRE的存在与异常的EEG发现或特定的MECP2突变基因型无关。意义:这些观察结果可能对实际管理和家庭咨询有帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号